Alliance for Clinical Trials in Oncology
3 clinical trials · 3 recruiting · OTHER
Trials by Alliance for Clinical Trials in Oncology
RECRUITINGPhase 3NCT06876714
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a...
This phase III trial compares 6 months of human epidermal growth factor receptor 2 (HER2)-targeted therapy to 12 months of HER2-targeted therapy for the treatment of HER2-positive...
Sponsor: Alliance for Clinical Trials in OncologyEnrolling: 152420 locations
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Early Stage Breast Carcinoma
RECRUITINGPhase 3NCT07000084
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle...
This phase III trial compares the effect of adding gemcitabine to intravesical Bacillus Calmette Guerin (BCG) versus intravesical BCG alone in patients with non-muscle invasive...
Sponsor: Alliance for Clinical Trials in OncologyEnrolling: 33020 locations
Recurrent Non-Muscle Invasive Bladder CarcinomaStage 0a Bladder Cancer AJCC v8Stage I Bladder Cancer AJCC v8
RECRUITINGPhase 2NCT05647265
Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma
This phase II trial evaluates the safety and effectiveness of giving immunotherapy (nivolumab and ipilimumab) before surgery for controlling disease in patients with stage I-IIIa...
Sponsor: Alliance for Clinical Trials in OncologyEnrolling: 2620 locations
Pleural Biphasic MesotheliomaPleural Sarcomatoid Mesothelioma